MENLO PARK, Calif., June 1, 2023 /PRNewswire/ -- Enable Medicine, a leader in AI for biological research and drug discovery, is proud to announce the launch of Generative Biological Search (GBS). This marks the first integration of large language models (LLMs), biological data, and productionized research workflows in the field.
"GBS simplifies the research process and expands the discoverability of data" said Aaron Mayer, CSO of Enable Medicine. "More importantly, this establishes an integrated foundation for us to rapidly build capabilities in-step with the speed at which AI is advancing."
Generative Biological Search represents a significant leap in enabling end-to-end biological research. By harnessing LLMs, researchers can now perform sophisticated analyses with natural language rather than code. As the platform is refined, we expect this will make the field more accessible, make the field more productive, and ultimately accelerate the pace of scientific discovery.
Select features include:
Generative Biological Search is set to revolutionize the way biological and medical research is conducted. This release is only the first step.
To learn more click here.
About Enable Medicine
Enable Medicine harnesses the revolutionary capabilities of AI to provide cutting-edge insights into biology and medicine. Our platform unlocks the power of generative biological search, enabling researchers to answer complex questions about disease. Our global network of partners leverage the platform to guide target discovery, identify new biomarkers, and develop optimal treatment strategies.
SOURCE Enable Medicine
Share this article